Table of Contents

Chapter 1 Report Scope
1.1 Market Segmentation and Scope
1.2 Regional Scope
1.3 Estimates and Forecast Timeline
Chapter 2 Research Methodology
2.1 Research Methodology
2.1.1 Information procurement
2.2 Information or Data Analysis
2.3 Market Formulation & Validation
2.4 Region-Wise Market Calculation
2.4.1 Region-Wise Market: Base Estimates
2.4.2 Global Market: CAGR Calculation
2.5 Region-Based Segment Share Calculation
2.6 Model Details
2.6.1 Commodity Flow Analysis (Model 1)
2.6.2 Volume price analysis (Model 2)
2.7 List of Secondary Sources
Chapter 3 Objectives
3.1 Objective – 1:
3.2 Objective – 2:
3.3 Objective – 3:
3.4 Objective – 4:
Chapter 4 Executive Summary
4.1 Market Outlook
4.2 Segment Outlook
4.3 Competitive Insights
4.4 Market Snapshot
Chapter 5 Industry Outlook
5.1 Penetration & Growth Prospect Mapping
5.2 Regulatory Framework
5.3 Market Dynamics
5.3.1 Market driver analysis
5.3.1.1 Increasing prevalence of chronic and acute wounds
5.3.1.2 Rising number of ambulatory surgery centers
5.3.1.3 Increasing number of accidents, burn injuries, and trauma cases
5.3.1.4 Surge in the number of surgeries
5.3.2 Market restraint analysis
5.3.2.1 Rising treatment costs
5.3.2.2 Increasing usage of alternative advanced wound care dressings
5.4 Anti-biofilm Wound Dressing Market Analysis Tools
5.4.1 SWOT Analysis, by PEST
5.4.2 Porter’s Five Forces analysis
5.5 Impact of COVID-110
5.5.1 Supply chain
5.5.2 Changing market trends
Chapter 6 Anti-biofilm Wound Dressing Market: Segment Analysis, By Mode of Mechanism, 2018 – 2030 (USD Million)
6.1 Definitions & Scope
6.2 Mode of Mechanism Market Share Analysis, 2022 & 2030
6.3 Anti-biofilm Wound Dressing Market, by Mode of Mechanism, 2018 to 2030
6.4 Market Size Forecasts and Trend Analysis
6.4.1 Physical
6.4.1.1 Physical market, 2018 – 2030 (USD Million)
6.4.1.2 Manual debridement
6.4.1.2.1 Manual debridement market, 2018 – 2030 (USD Million)
6.4.1.3 Pulse electrical field
6.4.1.3.1 Pulse electrical field market, 2018 – 2030 (USD Million)
6.4.1.4 Ultrasound debridement
6.4.1.4.1 Ultrasound debridement market, 2018 – 2030 (USD Million)
6.4.2 Chemical
6.4.2.1 Chemical market, 2018 – 2030 (USD Million)
6.4.2.2 Ionic silver
6.4.2.2.1 Ionic silver market, 2018 – 2030 (USD Million)
6.4.2.3 Iodine
6.4.2.3.1 Iodine market, 2018 – 2030 (USD Million)
6.4.2.4 EDTA
6.4.2.4.1 EDTA market, 2018 – 2030 (USD Million)
6.4.2.5 Others
6.4.2.5.1 Others market, 2018 – 2030 (USD Million)
6.4.3 Biological
6.4.3.1 Biological market, 2018 – 2030 (USD Million)
6.4.3.2 Dispersin B
6.4.3.2.1 Dispersin B market, 2018 – 2030 (USD Million)
6.4.3.3 Lactoferrin
6.4.3.3.1 Lactoferrin market, 2018 – 2030 (USD Million)
6.4.3.4 Bacteriophage
6.4.3.4.1 Bacteriophage market, 2018 – 2030 (USD Million)
6.4.3.5 Others
6.4.3.5.1 Others market, 2018 – 2030 (USD Million)
Chapter 7 Anti-biofilm Wound Dressing Market: Segment Analysis, By Application, 2018 – 2030 (USD Million)
7.1 Definitions & Scope
7.2 Application Market Share Analysis, 2022 & 2030
7.3 Anti-biofilm Wound Dressing Market, by Application, 2018 to 2030
7.4 Market Size Forecasts and Trend Analysis
7.4.1 Chronic wounds
7.4.1.1 Chronic wounds market, 2018 – 2030 (USD Million)
7.4.1.2 Diabetic foot ulcers
7.4.1.2.1 Diabetic foot ulcers market, 2018 – 2030 (USD Million)
7.4.1.3 Pressure ulcers
7.4.1.3.1 Pressure ulcers market, 2018 – 2030 (USD Million)
7.4.1.4 Venous leg ulcers
7.4.1.4.1 Venous leg ulcers market, 2018 – 2030 (USD Million)
7.4.1.5 Other chronic wounds
7.4.1.5.1 Other chronic wounds market, 2018 – 2030 (USD Million)
7.4.2 Acute wounds
7.4.2.1 Acute wounds market, 2018 – 2030 (USD Million)
7.4.2.2 Surgical & traumatic wounds
7.4.2.2.1 Surgical & traumatic wounds market, 2018 – 2030 (USD Million)
7.4.2.3 Burn wounds
7.4.2.3.1 Burn wounds market, 2018 – 2030 (USD Million)
Chapter 8 Chronic Wound Care Market: Segment Analysis, By End-use, 2018 – 2030 (USD Million)
8.1 Definitions & Scope
8.2 End-use Market Share Analysis, 2021 & 2030
8.3 Global Chronic Wound Care Market, by End-use, 2018 to 2030
8.4 Market Size Forecasts & Trend Analysis
8.4.1 Hospitals
8.4.1.1 Hospitals market, 2018 – 2030 (USD Million)
8.4.2 Specialty Clinics
8.4.2.1 Specialty clinics market, 2018 – 2030 (USD Million)
8.4.3 Home Healthcare
8.4.3.1 Home healthcare market, 2018 – 2030 (USD Million)
8.4.4 Others
8.4.4.1 Others market, 2018 – 2030 (USD Million)
Chapter 9 Anti-biofilm Wound Dressing Market: Regional Market Analysis, By Mode of Mechanism and Application, 2018 – 2030 (USD Million)
9.1 Definitions & Scope
9.2 Regional Market Share Analysis, 2022 & 2030
9.3 Regional Market Snapshot
9.4 Market Size Forecasts & Trend Analysis
9.4.1 North America
9.4.1.1 North America anti-biofilm wound dressing market, 2018 – 2030 (USD Million)
9.4.1.2 U.S.
9.4.1.2.1 U.S. anti-biofilm wound dressing market, 2018 – 2030 (USD Million)
9.4.1.3 Canada
9.4.1.3.1 Canada anti-biofilm wound dressing market, 2018 – 2030 (USD Million)
9.4.2 Europe
9.4.2.1 Europe anti-biofilm wound dressing market, 2018 – 2030 (USD Million)
9.4.2.2 U.K.
9.4.2.2.1 U.K. anti-biofilm wound dressing market, 2018 – 2030 (USD Million)
9.4.2.3 Germany
9.4.2.3.1 Germany anti-biofilm wound dressing market, 2018 – 2030 (USD Million)
9.4.2.4 France
9.4.2.4.1 France anti-biofilm wound dressing market, 2018 – 2030 (USD Million)
9.4.2.5 Italy
9.4.2.5.1 Italy anti-biofilm wound dressing market, 2018 – 2030 (USD Million)
9.4.2.6 Spain
9.4.2.6.1 Spain anti-biofilm wound dressing market, 2018 – 2030 (USD Million)
9.4.2.7 Sweden
9.4.2.7.1 Sweden anti-biofilm wound dressing market, 2018 – 2030 (USD Million)
9.4.2.8 Norway
9.4.2.8.1 Norway anti-biofilm wound dressing market, 2018 – 2030 (USD Million)
9.4.2.9 Denmark
9.4.2.9.1 Denmark anti-biofilm wound dressing market, 2018 – 2030 (USD Million)
9.4.3 Asia Pacific
9.4.3.1 Asia Pacific anti-biofilm wound dressing market, 2018 – 2030 (USD Million)
9.4.3.2 Japan
9.4.3.2.1 Japan anti-biofilm wound dressing market, 2018 – 2030 (USD Million)
9.4.3.3 China
9.4.3.3.1 China anti-biofilm wound dressing market, 2018 – 2030 (USD Million)
9.4.3.4 India
9.4.3.4.1 India anti-biofilm wound dressing market, 2018 – 2030 (USD Million)
9.4.3.5 Australia
9.4.3.5.1 Australia anti-biofilm wound dressing market, 2018 – 2030 (USD Million)
9.4.3.6 South Korea
9.4.3.6.1 South Korea anti-biofilm wound dressing market, 2018 – 2030 (USD Million)
9.4.3.7 Thailand
9.4.3.7.1 Thailand anti-biofilm wound dressing market, 2018 – 2030 (USD Million)
9.4.4 Latin America
9.4.4.1 Latin America anti-biofilm wound dressing market, 2018 – 2030 (USD Million)
9.4.4.2 Brazil
9.4.4.2.1 Brazil anti-biofilm wound dressing market, 2018 – 2030 (USD Million)
9.4.4.3 Mexico
9.4.4.3.1 Mexico anti-biofilm wound dressing market, 2018 – 2030 (USD Million)
9.4.4.3 Argentina
9.4.4.3.1 Argentina anti-biofilm wound dressing market, 2018 – 2030 (USD Million)
9.4.5 Middle East & Africa
9.4.5.1 Middle East & Africa anti-biofilm wound dressing market, 2018 – 2030 (USD Million)
9.4.5.2 South Africa
9.4.5.2.1 South Africa anti-biofilm wound dressing market, 2018 – 2030 (USD Million)
9.4.5.3 Saudi Arabia
9.4.5.3.1 Saudi Arabia anti-biofilm wound dressing market, 2018 – 2030 (USD Million)
9.4.5.4 UAE
9.4.5.4.1 UAE anti-biofilm wound dressing market, 2018 – 2030 (USD Million)
9.4.5.5 Kuwait
9.4.5.5.1 Kuwait anti-biofilm wound dressing market, 2018 – 2030 (USD Million)
Chapter 10 Anti-biofilm Wound Dressing Market: Competitive Analysis
10.1 Company Profiles
10.1.1 ConvaTec Inc.
10.1.1.1 Company overview
10.1.1.2 Financial performance
10.1.1.3 Product benchmarking
10.1.1.4 Strategic initiatives
10.1.2 Smith & Nephew PLC
10.1.2.1 Company overview
10.1.2.2 Financial performance
10.1.2.3 Product benchmarking
10.1.2.4 Strategic initiatives
10.1.3 Urgo Medical
10.1.3.1 Company overview
10.1.3.2 Financial performance
10.1.3.3 Product benchmarking
10.1.3.4 Strategic initiatives
10.1.4 Coloplast
10.1.4.1 Company overview
10.1.4.2 Financial performance
10.1.4.3 Product benchmarking
10.1.4.4 Strategic initiatives
10.1.5 3M
10.1.5.1 Company overview
10.1.5.2 Financial performance
10.1.5.3 Product benchmarking
10.1.5.4 Strategic initiatives
10.1.6 Mölnlycke Health Care AB
10.1.6.1 Company overview
10.1.6.2 Financial performance
10.1.6.3 Product benchmarking
10.1.6.4 Strategic initiatives
10.1.7 Imbed Biosciences
10.1.7.1 Company overview
10.1.7.2 Financial performance
10.1.7.3 Product benchmarking
10.1.7.4 Strategic initiatives
10.1.8 Next Science
10.1.8.1 Company overview
10.1.8.2 Financial performance
10.1.8.3 Product benchmarking
10.1.8.4 Strategic initiatives
10.1.9 B. Braun Melsungen AG
10.1.9.1 Company overview
10.1.9.2 Financial performance
10.1.9.3 Product benchmarking
10.1.9.4 Strategic initiatives
10.1.10 Lohmann & Rauscher
10.1.10.1 Company overview
10.1.10.2 Financial performance
10.1.10.3 Product benchmarking
10.1.10.4 Strategic initiatives